Skip to main content
Tessa NewsLink
Paste a health news link, or browse

Source study found

Story checked

A resource to help hospitals build the business case for diagnostic stewardship (opens in a new tab)

medicalxpress.com · 2026-09-11

Short answerEvidenceSource

Short answer

Mixed

Mixed.

One claim goes further than the study. One other point was not covered by the paper.

  • 4 supported
  • 1 overstated
  • 1 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mixed

One claim overstates the study. Four of six check out. One claim the study doesn't address.

  • 4 supported
  • 1 overstated
  • 1 not covered
Open claim evidence
3

The source study

A business case for diagnostic stewardship: a practical guide from the Society for Healthcare Epidemiology of America (SHEA) Diagnostic Stewardship Special Interest Group

Antimicrobial Stewardship & Healthcare Epidemiology · 2026
Open source record (opens in a new tab)
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

6 claims in this story

Showing all 6 claimsChoose a verdict to focus the list.

Claim 1 of 6OverstatedSHEA has published a new resource describing how diagnostic stewardship can improve patient outcomes, strengthen hospital quality metrics and reduce health care costs.View evidenceHide evidence

Why this verdict

The abstract-level profile supports that the paper is a practical business-case/modeling resource estimating cost savings and quality/reputation metric impacts for diagnostic stewardship interventions. However, the lead claim states unhedged that diagnostic stewardship can improve patient outcomes, strengthen quality metrics, and reduce costs. The paper profile does not report patient-level outcome data or an empirical intervention study; it describes modeled savings/metrics and background association with improved patient outcomes. The patient-outcome and cost-reduction framing therefore outruns the abstract evidence unless clearly limited to modeled/expected effects.

1

Study evidence

CDI diagnostic stewardship modeled to yield $125,617 expected savings and a likely 75% reduction in the hospital-acquired CDI metric for a 200-bed hospital.$125,617; 75% reduction (HAC CDI)

“We examined five common targets for diagnostic stewardship… For each, we estimated the financial and reputational impact of each intervention on a typical 200 bed community hospital. These estimates can be adjusted for individual hospital estimates.”
2

Study evidence

CDI diagnostic stewardship showed $125,617 expected savings plus a likely additional 75% reduction in the HAC CDI metric.$125,617; 75% reduction (HAC CDI)

“Clostridioides difficile (CDI) diagnostic stewardship showed $125,617 expected savings plus a likely additional 75% reduction in the hospital-acquired condition (HAC) CDI metric.”
Claim 2 of 6Not coveredThe authors say the framework helps hospitals evaluate and implement diagnostic stewardship in ways that improve clinical outcomes, strengthen quality metrics and demonstrate measurable value.View evidenceHide evidence

Why this verdict

The broad idea that the framework helps hospitals evaluate diagnostic stewardship value is consistent with the abstract profile. However, the exact quoted author statement is not present in the supplied abstract-level quoted spans, and the abstract profile does not verify the full wording that implementation through the framework improves clinical outcomes. At abstract depth, the exact quote and clinical-outcome assertion cannot be fully verified.

1

Study evidence

CDI diagnostic stewardship modeled to yield $125,617 expected savings and a likely 75% reduction in the hospital-acquired CDI metric for a 200-bed hospital.$125,617; 75% reduction (HAC CDI)

“We examined five common targets for diagnostic stewardship… For each, we estimated the financial and reputational impact of each intervention on a typical 200 bed community hospital. These estimates can be adjusted for individual hospital estimates.”
2

Study evidence

CDI diagnostic stewardship showed $125,617 expected savings plus a likely additional 75% reduction in the HAC CDI metric.$125,617; 75% reduction (HAC CDI)

“Clostridioides difficile (CDI) diagnostic stewardship showed $125,617 expected savings plus a likely additional 75% reduction in the hospital-acquired condition (HAC) CDI metric.”
Claim 3 of 6SupportedThe paper, published in Antimicrobial Stewardship and Healthcare Epidemiology, provides a framework for developing institution-specific business cases for diagnostic stewardship programs, including financial models for five high-impact interventions.View evidenceHide evidence

Why this verdict

The profile describes a practical business-case model/framework with institution-adjustable estimates for five diagnostic stewardship targets, including financial savings models and quality/reputation metric impacts. The journal/publication metadata is not independently detailed in the abstract profile, but the substantive claim about the paper's framework and five intervention models is supported.

1

Study evidence

CDI diagnostic stewardship modeled to yield $125,617 expected savings and a likely 75% reduction in the hospital-acquired CDI metric for a 200-bed hospital.$125,617; 75% reduction (HAC CDI)

“We examined five common targets for diagnostic stewardship… For each, we estimated the financial and reputational impact of each intervention on a typical 200 bed community hospital. These estimates can be adjusted for individual hospital estimates.”
2

Study evidence

CDI diagnostic stewardship showed $125,617 expected savings plus a likely additional 75% reduction in the HAC CDI metric.$125,617; 75% reduction (HAC CDI)

“Clostridioides difficile (CDI) diagnostic stewardship showed $125,617 expected savings plus a likely additional 75% reduction in the hospital-acquired condition (HAC) CDI metric.”
Claim 4 of 6SupportedAs an example, the authors estimate that a representative 200-bed community hospital implementing all five interventions could generate approximately $2.5 million to $2.8 million in annual laboratory and clinical savings.View evidenceHide evidence

As statedapproximately $2.5 million to $2.8 million in annual laboratory and clinical savings

Why this verdict

The abstract profile states that a typical 200-bed hospital implementing all five interventions could expect approximately $2,482,616–$2,825,216 in laboratory and clinical savings. The story's $2.5 million to $2.8 million estimate is an accurate rounded version and is appropriately hedged as an estimate.

1

Study evidence

CDI diagnostic stewardship modeled to yield $125,617 expected savings and a likely 75% reduction in the hospital-acquired CDI metric for a 200-bed hospital.$125,617; 75% reduction (HAC CDI)

“We examined five common targets for diagnostic stewardship… For each, we estimated the financial and reputational impact of each intervention on a typical 200 bed community hospital. These estimates can be adjusted for individual hospital estimates.”
2

Study evidence

CDI diagnostic stewardship showed $125,617 expected savings plus a likely additional 75% reduction in the HAC CDI metric.$125,617; 75% reduction (HAC CDI)

“Clostridioides difficile (CDI) diagnostic stewardship showed $125,617 expected savings plus a likely additional 75% reduction in the hospital-acquired condition (HAC) CDI metric.”
Claim 5 of 6SupportedDepending on baseline performance, improved quality metrics could also reduce CMS Hospital-Acquired Condition penalties by an estimated $200,000 to $600,000.View evidenceHide evidence

As stated$200,000 to $600,000

Why this verdict

The profile reports additional HAC-related savings estimated at $200,000–$600,000 depending on baseline performance. The story's framing as CMS Hospital-Acquired Condition penalty reductions is consistent with the HAC-metric/penalty context represented in the profile, and the claim preserves the baseline-performance caveat.

1

Study evidence

CDI diagnostic stewardship modeled to yield $125,617 expected savings and a likely 75% reduction in the hospital-acquired CDI metric for a 200-bed hospital.$125,617; 75% reduction (HAC CDI)

“We examined five common targets for diagnostic stewardship… For each, we estimated the financial and reputational impact of each intervention on a typical 200 bed community hospital. These estimates can be adjusted for individual hospital estimates.”
2

Study evidence

CDI diagnostic stewardship showed $125,617 expected savings plus a likely additional 75% reduction in the HAC CDI metric.$125,617; 75% reduction (HAC CDI)

“Clostridioides difficile (CDI) diagnostic stewardship showed $125,617 expected savings plus a likely additional 75% reduction in the hospital-acquired condition (HAC) CDI metric.”
Claim 6 of 6SupportedThe five common opportunities for improvement are optimizing Clostridioides difficile testing, optimizing urine culture use, de-implementing unnecessary procalcitonin testing, optimizing respiratory pathogen panel use, and optimizing blood culture use.View evidenceHide evidence

As statedfive common opportunities for improvement

Why this verdict

The five listed opportunities match the five intervention targets in the abstract profile: CDI testing stewardship, urine culture stewardship, procalcitonin de-implementation, expanded respiratory pathogen panel stewardship, and blood culture stewardship.

1

Study evidence

CDI diagnostic stewardship modeled to yield $125,617 expected savings and a likely 75% reduction in the hospital-acquired CDI metric for a 200-bed hospital.$125,617; 75% reduction (HAC CDI)

“We examined five common targets for diagnostic stewardship… For each, we estimated the financial and reputational impact of each intervention on a typical 200 bed community hospital. These estimates can be adjusted for individual hospital estimates.”
2

Study evidence

CDI diagnostic stewardship showed $125,617 expected savings plus a likely additional 75% reduction in the HAC CDI metric.$125,617; 75% reduction (HAC CDI)

“Clostridioides difficile (CDI) diagnostic stewardship showed $125,617 expected savings plus a likely additional 75% reduction in the hospital-acquired condition (HAC) CDI metric.”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • The abstract does not provide detailed model inputs, parameter values, data sources, uncertainty ranges, or sensitivity analyses.

    The story notes that estimates depend on baseline performance and are part of a business-case guide, but it does not mention the abstract-level limitation that the underlying assumptions, parameters, data sources, and uncertainty/sensitivity analyses are not provided.

    From Business-case economic modeling / scenario-based estimation; Intervention-by-intervention, assumption-based economic est

6 things the story did carry across
  • The paper is a business-case economic modeling/scenario-estimation exercise, not a prospective or retrospective patient-level intervention study.
  • The model uses a hypothetical or 'typical' 200-bed community hospital, with estimates intended to be adjustable for local hospital assumptions.
  • The five modeled diagnostic stewardship targets are CDI testing stewardship, urine culture stewardship, procalcitonin de-implementation, respiratory pathogen panel stewardship, and blood culture stewardship.
  • Aggregate implementation of all five interventions is modeled to produce approximately $2,482,616–$2,825,216 in laboratory and clinical savings.
  • Additional HAC-related savings are estimated at $200,000–$600,000 and depend on baseline performance.
  • The abstract reports projected improvements in HAC and reputation metrics, such as CDI, CAUTI, CLABSI/MRSA bacteremia metrics and Leapfrog-type reputation metrics.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

2

Evidence read

study summary

Lead result

other

1Lead resultotherProvide a practical business-case model estimating financial savings and quality/reputation metric impacts for five common diagnostic stewardship interventions in a “typical” 200-bed community hospital.Business-case economic modeling / scenario-based estimationExpand

In plain English

Modeling/business-case estimation of financial savings and impacts on hospital-acquired condition (HAC) and reputation metrics for five diagnostic stewardship interventions applied to a hypothetical 200-bed community hospital. Outputs are expected dollar savings ranges per intervention, projected percentage reductions in selected HAC metrics, aggregate savings if all five interventions implemented, and potential additional HAC/reputation-related savings.

Key findings

  • CDI diagnostic stewardship modeled to yield $125,617 expected savings and a likely 75% reduction in the hospital-acquired CDI metric for a 200-bed hospital.$125,617; 75% reduction (HAC CDI)
  • Urine culture stewardship modeled to produce $34,111–$92,361 in savings and a 30% reduction in the HAC catheter-associated urinary tract infection metric.$34,111–$92,361; 30% reduction (HAC CAUTI)
“We examined five common targets for diagnostic stewardship… For each, we estimated the financial and reputational impact of each intervention on a typical 200 bed community hospital. These estimates can be adjusted for individual hospital estimates.”
What this piece can’t prove
  • Abstract reports a modeling/business-case exercise for a hypothetical 200-bed community hospital; not a primary patient-level or observational study.

2 further details could not be confirmed from the summary.

2otherOffer intervention-specific estimated savings and expected reductions in selected hospital-acquired condition (HAC) metrics (CDI, CAUTI, CLABSI/MRSA bacteremia) and reputation metrics (eg, Leapfrog) as adjustable reference estimates for local adaptation.Intervention-by-intervention, assumption-based economic estimates for a typical 200-bed community hospital (abstract-level)Expand

In plain English

Abstract reports intervention-specific, modelled reference estimates of expected laboratory/clinical savings and projected reductions in selected hospital-acquired condition (HAC) metrics for five diagnostic-stewardship targets, using a "typical 200-bed community hospital" framing and offering ranges/scenarios that are adjustable for local adaptation.

Key findings

  • CDI diagnostic stewardship showed $125,617 expected savings plus a likely additional 75% reduction in the HAC CDI metric.$125,617; 75% reduction (HAC CDI)
  • Urine culture stewardship showed $34,111–$92,361 in savings with an additional 30% reduction in the HAC catheter-associated urinary tract infection metric.$34,111–$92,361; 30% reduction (HAC CAUTI)
“Clostridioides difficile (CDI) diagnostic stewardship showed $125,617 expected savings plus a likely additional 75% reduction in the hospital-acquired condition (HAC) CDI metric.”
What this piece can’t prove
  • Estimates are scenario- and assumption-driven for a "typical 200-bed" hospital and may not generalize without local recalculation.

2 further details could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Open the paper in Tessa

A business case for diagnostic stewardship: a practical guide from the Society for Healthcare Epidemiology of America (SHEA) Diagnostic Stewardship Special Interest Group

Antimicrobial Stewardship & Healthcare Epidemiology · 2026

Source record (opens in a new tab)

Why this one

Near certain

NewsLink found the paper. Tessa is where you inspect it deeply.

Papers considered

The selected paper, plus nearby candidates.

Crossref, PubMed, Europe PMC · 37 candidate papers

Selected

A business case for diagnostic stewardship: a practical guide from the Society for Healthcare Epidemiology of America (SHEA) Diagnostic Stewardship Special Interest Group

Antimicrobial Stewardship & Healthcare Epidemiology · 2026 · Crossref

Source (opens in a new tab)
Candidate

Colonizer or Culprit? Significance of Stenotrophomonas maltophilia in Urine Cultures

Antimicrobial Stewardship & Healthcare Epidemiology · 2026 · Crossref

Source (opens in a new tab)
Candidate

Persuasion & influence: practical tips for the infection prevention and antimicrobial stewardship leader

Antimicrobial Stewardship & Healthcare Epidemiology · 2026 · Crossref

Source (opens in a new tab)
Candidate

Assessing the impact of antimicrobial stewardship in low-income healthcare settings: a study of antibiotic use and antimicrobial susceptibility patterns in Indian hospitals

Antimicrobial Stewardship & Healthcare Epidemiology · 2026 · Crossref

Tessa (opens in a new tab)Source (opens in a new tab)

And 31 more candidates considered.